1. Melanoma;Kirkwood,1995
2. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule;Slaton;Clin. Cancer Res.,1999
3. Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic melagnant melanoma;Falkson;J. Clin. Oncol.,1991
4. Interferon-alpha 2a does not improve response or survival when combined with dacarbazide in metastatic malignant melanoma;Tompson;Melanoma Res.,1993
5. Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma;Sparano;J. Clin. Oncol.,1993